Picibanil

N/A

Report date: 2026/01/14 15:27:01

Base Information

Drug NamePicibanil
Drug Alias NameSapylin溶链菌制剂溶链菌素溶血链球菌制剂溶链菌 +[9] 
ClassificationBiologicsNatural product/Extract > Microbial extract
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAscitesLymphatic AbnormalitiesLung Neoplasms +[8] 
Global Approved IndicationsAscitesLung NeoplasmsHead and Neck Neoplasms +[6] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2006/08/17
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesChugai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChugai Pharmaceutical Co Ltd
Inactive CompaniesThe University Of IowaFukushima Medical University
Active IndicationsAscitesLung NeoplasmsHead and Neck Neoplasms +[6] 
Inactive IndicationsLymphatic AbnormalitiesPancreatic Neoplasms

Other Information

ATC CodeL03AX
Related LinksWikipediaDrugBankKEGG